Atomic Interactions and Profile of Small Molecules Disrupting Protein-Protein Interfaces: the TIMBAL Database

被引:141
作者
Higueruelo, Alicia P. [1 ]
Schreyer, Adrian [1 ]
Bickerton, G. Richard J. [1 ]
Pitt, Will R. [1 ,2 ]
Groom, Colin R. [3 ]
Blundell, Tom L. [1 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
[2] UCB Celltech, Slough, Berks, England
[3] Cambridge Crystallog Data Ctr, Cambridge, England
基金
英国生物技术与生命科学研究理事会;
关键词
CREDO; database; druggable; drugs; multi-protein complexes; PICCOLO; protein-protein interactions; small molecules; TIMBAL; STRUCTURE-BASED DESIGN; HUMAN-PAPILLOMAVIRUS TYPE-11; E2 TRANSACTIVATION DOMAIN; ZIPA-FTSZ INTERACTION; LIGAND INTERACTION; POTENT INHIBITORS; DRUG CANDIDATES; BCL-2; PROTEINS; LEAD DISCOVERY; BINDING-SITE;
D O I
10.1111/j.1747-0285.2009.00889.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence of the possibility of modulating protein-protein interactions with small molecules is opening the door to new approaches and concepts in drug discovery. In this paper, we describe the creation of TIMBAL, a hand-curated database holding an up to date collection of small molecules inhibiting multi-protein complexes. This database has been analysed and profiled in terms of molecular properties. Protein-protein modulators tend to be large lipophilic molecules with few hydrogen bond features. An analysis of TIMBAL's intersection with other structural databases, including CREDO (protein-small molecule from the PDB) and PICCOLO (protein-protein from the PDB) reveals that TIMBAL molecules tend to form mainly hydrophobic interactions with only a few hydrogen bonding contacts. With respect to potency, TIMBAL molecules are slightly less efficient than an average medicinal chemistry hit or lead. The database provides a resource that will allow further insights into the types of molecules favoured by protein interfaces and provide a background to continuing work in this area. Access at http://www-cryst.bioc.cam.ac.uk/timbal.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 61 条
[1]  
Adair J.R., 2005, DRUG DESIGN REV ONLI, V2, P209
[2]   A gene-expression inhibitor that targets an α-helix-mediated protein interaction [J].
Asada, S ;
Choi, YM ;
Uesugi, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (17) :4992-4993
[3]   Modulation of protein-protein interactions with small organic molecules [J].
Berg, T .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (22) :2462-2481
[4]  
Berg T, 2008, CURR OPIN DRUG DISC, V11, P666
[5]   Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery [J].
Blundell, TL ;
Sibanda, BL ;
Montalvao, RW ;
Brewerton, S ;
Chelliah, V ;
Worth, CL ;
Harmer, NJ ;
Davies, O ;
Burke, D .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1467) :413-423
[6]   Bioactivation and hepatotoxicity of nitroaromatic drugs [J].
Boelsterli, Urs A. ;
Ho, Han Kiat ;
Zhou, Shufeng ;
Leow, Koon Yeow .
CURRENT DRUG METABOLISM, 2006, 7 (07) :715-727
[7]   Studies leading to potent, dual inhibitors of bcl-2 and Bcl-xL [J].
Bruncko, Milan ;
Oost, Thorsten K. ;
Belli, Barbara A. ;
Ding, Hong ;
Joseph, Mary K. ;
Kunzer, Aaron ;
Martineau, Darlene ;
McClellan, William J. ;
Mitten, Michael ;
ng, Shi-Chu Ng ;
Nimmer, Paul M. ;
Oltersdorf, Tilman ;
Park, Cheol-Min ;
Petros, Andrew M. ;
Shoemaker, Alexander R. ;
Song, Xiaohong ;
Wang, Xilu ;
Wendt, Michael D. ;
Zhang, Haichao ;
Fesik, Stephen W. ;
Rosenberg, Saul H. ;
Elmore, Steven W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) :641-662
[8]   Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein [J].
Chen, Jianyong ;
Nikolovska-Coleska, Zaneta ;
Wang, Guoping ;
Qiu, Su ;
Wang, Shaomeng .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (22) :5805-5808
[9]   A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export [J].
Daelemans, D ;
Afonina, E ;
Nilsson, J ;
Werner, G ;
Kjems, J ;
De Clercq, E ;
Pavlakis, GN ;
Vandamme, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14440-14445
[10]   Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 Transactivation domain by photoaffinity labeling and mass spectrometry [J].
Davidson, W ;
McGibbon, GA ;
White, PW ;
Yoakim, C ;
Hopkins, JL ;
Guse, I ;
Hambly, DM ;
Frego, L ;
Ogilvie, WW ;
Lavallée, P ;
Archambault, J .
ANALYTICAL CHEMISTRY, 2004, 76 (07) :2095-2102